20. Non Hodgkin's Lymphoma | USMLE Step 1 Pathology
๐ ๐ ๐จ๐ฅ๐ฅ๐จ๐ฐ ๐จ๐ง ๐๐ง๐ฌ๐ญ๐๐ ๐ซ๐๐ฆ:- ย ย /ย drgbhanuprakashย ย ๐๐๐ผ๐ถ๐ป ๐ข๐๐ฟ ๐ง๐ฒ๐น๐ฒ๐ด๐ฟ๐ฎ๐บ ๐๐ต๐ฎ๐ป๐ป๐ฒ๐น ๐๐ฒ๐ฟ๐ฒ:- https://t.me/bhanuprakashdr ๐๐ฆ๐๐ฏ๐๐ฐ๐ฟ๐ถ๐ฏ๐ฒ ๐ง๐ผ ๐ ๐ ๐ ๐ฎ๐ถ๐น๐ถ๐ป๐ด ๐๐ถ๐๐:- https://linktr.ee/DrGBhanuprakash Non-Hodgkin's Lymphoma (NHL) for USMLE Step 1 Pathology Non-Hodgkin's Lymphoma (NHL) encompasses a heterogeneous group of lymphoid malignancies characterized by the proliferation of abnormal lymphocytes. Unlike Hodgkin's lymphoma, NHL lacks the characteristic Reed-Sternberg cells. This diverse group of diseases originates from B cells, T cells, or natural killer (NK) cells, each with distinct clinical presentations, histological features, and treatment modalities. Common subtypes include diffuse large B-cell lymphoma (DLBCL), follicular lymphoma, and mantle cell lymphoma. The pathogenesis of NHL involves genetic alterations, including chromosomal translocations, gene mutations, and dysregulation of cellular pathways involved in lymphocyte proliferation and survival. Risk factors for NHL include immunodeficiency states, viral infections (e.g., Epstein-Barr virus, human T-cell lymphotropic virus), exposure to ionizing radiation, and certain chemical agents. Diagnosis relies on histopathological examination of lymph node or extranodal tissue biopsies, immunophenotyping, and molecular studies to classify the subtype accurately. Treatment strategies vary depending on the subtype, stage, and patient factors but may include chemotherapy, immunotherapy, targeted therapy, and stem cell transplantation. Prognosis varies widely among NHL subtypes, with some exhibiting aggressive behavior requiring prompt intervention, while others follow an indolent course with a more favorable prognosis. Understanding the epidemiology, pathology, clinical features, and management of NHL is essential for medical students preparing for the USMLE Step 1 examination, as it represents a common topic in pathology and oncology. ๐๐ป #USMLE #Pathology #NonHodgkinsLymphoma #MedicalEducation #Pathophysiology #Oncology #Hematology #MedSchool #StudyResources #MedTwitter #CancerAwareness #fmge #fmgevideos #rapidrevisionfmge #fmgejan2023 #mbbslectures #nationalexitexam #nationalexittest #neetpg #usmlepreparation #usmlestep1 #fmge #usmle #drgbhanuprakash #medicalstudents #medicalstudent #medicalcollege #neetpg2023 #usmleprep #usmlevideos #usmlestep1videos #medicalstudents #neetpgvideos #nonhodgkinslymphoma

Lymphoma | Comprehensive Pathology | NEET PG | Dr.Priyanka Sachdev

Lymphoma | Clinical Medicine

Lymphoma Focus Day Low grade non Hodgkin lymphoma Rob Lown

How I Scored 281 on Step 2 (100th percentile) USMLE exam

Lymphoma

15. Acute Lymphoblastic Leukemia (ALL) | USMLE Step 1 Pathology

Super simplified Pathology | Leukemias and Lymphomas | Dr Priyanka Sachdev | Unacademy NEET PG

Non-hodgkin lymphoma - causes, symptoms, diagnosis, treatment, pathology

5. Lung Cancer (NSCLC and SCLC) | USMLE Step 1 Pathology

Differences Between Hodgkin's and Non Hodgkin's Lymphoma๐ฉบ

Understanding Multiple Myeloma (Multiple Myeloma Explained Clearly)

Non Hodgkin lymphoma | Pathology and genetics of Non Hodgkin lymphoma | Diagnosis and treatment

15. Alcoholic Hepatitis | USMLE Step 1 Pathology

Lymphoma | Podcast

14. Plasma Cell Disorders | USMLE Step 1 Pathology

17. Chronic Leukemias : CML and CLL | USMLE Step 1 Pathology

Conquer NEET PG 2022: Systemic | Pneumonia | Pathology | Let's crack NEET PG | Dr.Priyanka Sachdev

Hodgkin's Lymphoma Explained (With Classification)

Non Hodgkins Lymphoma - Types and Pathophysiology

